Evidence map›Paper›PMID 38717905›Full record

ArticleCell reports2024

Circadian-clock-controlled endocrine and cytokine signals regulate multipotential innate lymphoid cell progenitors in the bone marrow.

Qingyang Liu, Shams Tabrez, Patrick Niekamp, Chang H Kim

Abstract read
In one paragraph

Article in Cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Group 2 innate lymphoid cells: Where are we 15 years out?The Journal of allergy and clinical immunology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Circadian clock and cancer.Military Medical Research · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. [Application of exchange transfusion in neonates with severe pertussis and hyperleukocytosis].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qingyang LiuDepartment of Pathology, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA; Mary H. Weiser Food Allergy Center, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA; Immunology Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA.
Shams TabrezDepartment of Pathology, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA; Mary H. Weiser Food Allergy Center, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA.
Patrick NiekampDepartment of Pathology, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA; Mary H. Weiser Food Allergy Center, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA.
Chang H KimDepartment of Pathology, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA; Mary H. Weiser Food Allergy Center, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA; Immunology Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA. Electronic address: chhkim@umich.edu.

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
Homing of Functionally Distinct ILC SubsetsR01AI121302 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, CHANG H · 2016 to 2020
$1.9M
Mobilization and trafficking of central ILC progenitorsR01AI173179 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHANG H KIM · 2023 to 2026
$1.7M
Regulation of the development of dendritic cells in barrier tissues by retinoid gradientsR21AI148898 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, CHANG H · 2020 to 2021
$414k
Mobilization and trafficking of central ILC progenitorsR56AI173179 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, CHANG H · 2023 to 2023
$148k
NCI NIH HHS P30 CA046592NIAID NIH HHS R01 AI121302NIAID NIH HHS R01 AI173179NIAID NIH HHS R21 AI148898NIAID NIH HHS R56 AI173179
6 · The paper itself

Abstract

Innate lymphoid cells (ILCs), strategically positioned throughout the body, undergo population declines over time. A solution to counteract this problem is timely mobilization of multipotential progenitors from the bone marrow. It remains unknown what triggers the mobilization of bone marrow ILC progenitors (ILCPs). We report that ILCPs are regulated by the circadian clock to emigrate and generate mature ILCs in the periphery. We found that circadian-clock-defective ILCPs fail to normally emigrate and generate ILCs. We identified circadian-clock-controlled endocrine and cytokine cues that, respectively, regulate the retention and emigration of ILCPs at distinct times of each day. Activation of the stress-hormone-sensing glucocorticoid receptor upregulates CXCR4 on ILCPs for their retention in the bone marrow, while the interleukin-18 (IL-18) and RORα signals upregulate S1PR1 on ILCPs for their mobilization to the periphery. Our findings establish important roles of circadian signals for the homeostatic efflux of bone marrow ILCPs.

Indexed as

Circadian ClocksAnimalsBone MarrowBone Marrow CellsCell MovementCytokinesImmunity, InnateLymphocytesLymphoid Progenitor CellsMiceMice, Inbred C57BLNuclear Receptor Subfamily 1, Group F, Member 1Receptors, CXCR4Receptors, GlucocorticoidSignal TransductionCytokinesNuclear Receptor Subfamily 1, Group F, Member 1Receptors, CXCR4Receptors, Glucocorticoidbone marrowcircadian clockCP: ImmunologyCP: MetabolismglucocorticoidIL-18ILCPILC progenitorsmobilizationRORα

Identifiers

PMID38717905
PMCPMC11264331

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.